Default: Alzheimer's Research and Therapy

ISSN:

Journal Home

Journal Guideline

Alzheimer's Research and Therapy Q1 Unclaimed

BioMed Central Ltd. United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Alzheimer's Research and Therapy is a journal indexed in SJR in Neurology (clinical) and Cognitive Neuroscience with an H index of 77. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1529 €. The scope of the journal is focused on Alzheimer's disease, dementia, neurodegenerative diseases. It has an SJR impact factor of 2,315 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,315.

Alzheimer's Research and Therapy focuses its scope in these topics and keywords: alzheimer’s, disease, patients, memory, amyloid, impairment, diseaselongitudinal, learning, interventionsreactions, implications, ...

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Price

1529 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Alzheimer's Research and Therapy

2,315

SJR Impact factor

77

H Index

197

Total Docs (Last Year)

401

Total Docs (3 years)

10620

Total Refs

3086

Total Cites (3 years)

398

Citable Docs (3 years)

7.77

Cites/Doc (2 years)

53.91

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


alzheimer’s, disease, patients, memory, amyloid, impairment, diseaselongitudinal, learning, interventionsreactions, implications, identification, healthy, frontotemporal, ability, apoe?associated, fear, expansionscharacterization, endophenotypes, elevated, amyloidosisdatadriven, diseaseagerelated, dental, dementia, default, decline, crnd, correlate, corf, amalgam, conditioned, communitydwelling, clinical, cerebrospinal, burden, Alzheimer's disease, dementia, neurodegenerative diseases

FAQS